BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toulany M, Iida M, Keinath S, Iyi FF, Mueck K, Fehrenbacher B, Mansour WY, Schaller M, Wheeler DL, Rodemann HP. Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer. Oncotarget 2016;7:43746-61. [PMID: 27248324 DOI: 10.18632/oncotarget.9670] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Jiang W, Du Y, Zhu D, Zhang J, Fang C, Yan F, Chen Z. Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer. Drug Resistance Updates 2022;65:100884. [DOI: 10.1016/j.drup.2022.100884] [Reference Citation Analysis]
2 Alhaddad L, Osipov AN, Leonov S. The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance. IJMS 2022;23:13577. [DOI: 10.3390/ijms232113577] [Reference Citation Analysis]
3 Ashrafi A, Akter Z, Modareszadeh P, Modareszadeh P, Berisha E, Alemi PS, Chacon Castro MDC, Deese AR, Zhang L. Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance. Cancers 2022;14:4562. [DOI: 10.3390/cancers14194562] [Reference Citation Analysis]
4 Tatli O, Dinler Doganay G. Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy. Molecules 2021;26:7561. [PMID: 34946644 DOI: 10.3390/molecules26247561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Krysztofiak A, Szymonowicz K, Hlouschek J, Xiang K, Waterkamp C, Larafa S, Goetting I, Vega-Rubin-de-Celis S, Theiss C, Matschke V, Hoffmann D, Jendrossek V, Matschke J. Metabolism of cancer cells commonly responds to irradiation by a transient early mitochondrial shutdown. iScience 2021;24:103366. [PMID: 34825138 DOI: 10.1016/j.isci.2021.103366] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Gottifredi V. Targeting DNA damage response kinases in cancer therapy. Mutat Res 2020;821:111725. [PMID: 33157476 DOI: 10.1016/j.mrfmmm.2020.111725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Hintelmann K, Kriegs M, Rothkamm K, Rieckmann T. Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting. Front Oncol 2020;10:1260. [PMID: 32903756 DOI: 10.3389/fonc.2020.01260] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
8 Chen K, Shang Z, Dai AL, Dai PL. Novel PI3K/Akt/mTOR pathway inhibitors plus radiotherapy: Strategy for non-small cell lung cancer with mutant RAS gene. Life Sci 2020;255:117816. [PMID: 32454155 DOI: 10.1016/j.lfs.2020.117816] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
9 Nagasaka M, Li Y, Sukari A, Ou SI, Al-Hallak MN, Azmi AS. KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?Cancer Treat Rev. 2020;84:101974. [PMID: 32014824 DOI: 10.1016/j.ctrv.2020.101974] [Cited by in Crossref: 102] [Cited by in F6Publishing: 107] [Article Influence: 34.0] [Reference Citation Analysis]
10 Mortezaee K, Parwaie W, Motevaseli E, Mirtavoos-mahyari H, Musa AE, Shabeeb D, Esmaely F, Najafi M, Farhood B. Targets for improving tumor response to radiotherapy. International Immunopharmacology 2019;76:105847. [DOI: 10.1016/j.intimp.2019.105847] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 10.5] [Reference Citation Analysis]
11 Marampon F, Ciccarelli C, Zani BM. Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation. Int J Mol Sci 2019;20:E2530. [PMID: 31126017 DOI: 10.3390/ijms20102530] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
12 Toulany M. Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response. Genes (Basel) 2019;10:E25. [PMID: 30621219 DOI: 10.3390/genes10010025] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 19.0] [Reference Citation Analysis]
13 Zhu D, Zhou J, Zhao J, Jiang G, Zhang X, Zhang Y, Dong M. ZC3H13 suppresses colorectal cancer proliferation and invasion via inactivating Ras–ERK signaling. J Cell Physiol 2019;234:8899-907. [DOI: 10.1002/jcp.27551] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 11.2] [Reference Citation Analysis]
14 Blas K, Wilson TG, Tonlaar N, Galoforo S, Hana A, Marples B, Wilson GD. Dual blockade of PI3K and MEK in combination with radiation in head and neck cancer. Clin Transl Radiat Oncol 2018;11:1-10. [PMID: 30014041 DOI: 10.1016/j.ctro.2018.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
15 Su J, Huang H, Ju S, Shi J. Elevated RTP801 promotes cell proliferation in non-small cell lung cancer: ELEVATED RTP801 PROMOTES CELL PROLIFERATION IN NSCLC. IUBMB Life 2018;70:310-9. [DOI: 10.1002/iub.1727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
16 Vena F, Jia R, Esfandiari A, Garcia-Gomez JJ, Rodriguez-Justo M, Ma J, Syed S, Crowley L, Elenbaas B, Goodstal S, Hartley JA, Hochhauser D. MEK inhibition leads to BRCA2 downregulation and sensitization to DNA damaging agents in pancreas and ovarian cancer models. Oncotarget 2018;9:11592-603. [PMID: 29545922 DOI: 10.18632/oncotarget.24294] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
17 Park Y, Park JM, Kim DH, Kwon J, Kim IA. Inhibition of PI4K IIIα radiosensitizes in human tumor xenograft and immune-competent syngeneic murine tumor model. Oncotarget 2017;8:110392-405. [PMID: 29299156 DOI: 10.18632/oncotarget.22778] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
18 Mueck K, Rebholz S, Harati MD, Rodemann HP, Toulany M. Akt1 Stimulates Homologous Recombination Repair of DNA Double-Strand Breaks in a Rad51-Dependent Manner. Int J Mol Sci 2017;18:E2473. [PMID: 29156644 DOI: 10.3390/ijms18112473] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
19 Hu L, Wang H, Zhao Y, Wang J. 125I Seeds Radiation Induces Paraptosis-Like Cell Death via PI3K/AKT Signaling Pathway in HCT116 Cells. Biomed Res Int 2016;2016:8145495. [PMID: 28078301 DOI: 10.1155/2016/8145495] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
20 Li Y, Dong Q, Cui Y. Synergistic inhibition of MEK and reciprocal feedback networks for targeted intervention in malignancy. Cancer Biol Med 2019;16:415-34. [PMID: 31565475 DOI: 10.20892/j.issn.2095-3941.2019.0137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Reference Citation Analysis]